Comparison of three enzyme-linked immunosorbent assays for detection of immunoglobulin G antibodies to tetanus toxoid with reference standards and the impact on clinical practice

Clinical and Vaccine Immunology

Volumn 15, Issue 12, 2008, Pages 1751-1754

  Van Hoeven, Karen H ^a   Dale, Connie ^a   Foster, Phil ^b   Body, Barbara ^b  

^a Binding Site Group Ltd   (United Kingdom)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; TETANUS TOXOID;

ACCURACY; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOCOMPETENCE; IMMUNOGENICITY; PRIORITY JOURNAL; STANDARD;

ANTIBODIES, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TETANUS TOXOID;

EID: 57349198773     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00254-08     Document Type: Article

References (11)

1. Alagappan, K., W. Rennie, D. Lin, and C. Auerbach. 1998. Immunologic response to tetanus toxoid in the elderly: one-year follow-up. Ann. Emerg. Med. 32:155-160.
2. Bonilla, F. A., I. L. Bernstein, D. A. Khan, Z. K. Ballas, J. Chinen, M. M. Frank, L. J. Kobrynski, A. I. Levinson, B. Mazer, R. P. Nelson, Jr., J. S. Orange, J. M. Routes, W. T. Shearer, and R. U. Sorensen. 2005. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann. Allergy Asthma Immunol. 94:S1-S63.
3. Borrow, P., P. Balmer, and M. H. Roper. 2007. The immunologic basis for immunization series, module 3. Tetanus update 2006. WHO Press, Geneva, Switzerland. http://whqlibdoc.who.int/publications/2007/9789241595551_eng.pdf.
4. Broder, K. R., M. M. Cortese, J. K. Iskander, K. Kretsinger, B. A. Slade, K. H. Brown, C. M. Mijalski, T. Tiwari, E. J. Weston, A. C. Cohn, P. U. Srivastava, J. S. Moran, B. Schwartz, and T. V. Murphy. 2006. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. MMWR Recomm. Rep. 55(RR03):1-34.
5. de La Chapelle, A., O. Lavabre, M. Pinsard, J. Delamonica, and E. H. Relyveld. 2002. Tetanus in a renal transplant recipient exhibiting the presence of circulating antitetanus antibodies determined by ELISA. Biomed. Pharmacother. 56:208-210.
6. Grimprel, E., F. von Sonnenburg, R. Sanger, V. Abitbol, J. M. Wolter, and L. M. Schuerman. 2005. Combined reduced-antigen-content diphtheriatetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Vaccine 23:3657-3667.
7. Kretsinger, K., K. R. Broder, M. M. Cortese, M. P. Joyce, I. Ortega-Sanchez, G. M. Lee, T. Tiwari, A. C. Cohn, B. A. Slade, J. K. Iskander, C. M. Mijalski, K. H. Brown, and T. V. Murphy. 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Recomm. Rep. 55(RR17):1-37.
8. Mayorga, C., M. J. Torres, J. L. Corzo, J. Alvarez, J. A. Garcia, C. A. Rodriguez, M. Blanca, and A. Jurado. 2003. Immediate allergy to tetanus toxoid vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann. Allergy Asthma Immunol. 90:238-243.
9. National Institute for Biologic Standards and Control. 2008. WHO International Standard. First International Standard for Tetanus Immunoglobulin, human NIBSC code: TE-3. NIBSC, Potters Bar, Hertfordshire, United Kingdom. http://www.nibsc.ac.uk/documents/ifu/TE-3.pdf.
10. Sesardic, D., M. Y. Wong, R. E. Gaines Das, and M. J. Corbel. 1993. The first international standard for antitetanus immunoglobulin, human: pharmaceutical evaluation and international collaborative study. Biologicals 21:67-75.
11. Shohat, T., E. Marva, Y. Sivan, I. Lerman, A. Mates, and A. Cohen. 2000. Immunologic response to a single dose of tetanus toxoid in older people. J. Am. Geriatr. Soc. 48:949-951.